RSSCategory: Patient Advocacy

FDA Approval of Immunotherapy For MSI-High or Mismatch Repair Deficient Tumors

| June 5, 2017 | 0 Comments

Last month the FDA approved pembrolizumab (KEYTRUDA) for adult and pediatric patients with with metastatic or unresectable, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) solid tumors that have progressed following prior treatment. KEYTRUDA has also been approved fro MSI-H or dMMR colorectal cancers that have progressed following treatment with conventional chemotherapies. The immunooncology/immunotherapy story is fascinating. […]

Continue Reading

What is Wrong with the Veterans Administrations Hospitals?

| May 29, 2017 | 0 Comments

This past Memorial Day weekend I gave a lot of thought to those who have passed defending our freedoms and way of life as well as those who have served and survived to be cared for by our society. About 3 years ago stories began to break about a scandal involving a Veterans Administration (VA) […]

Continue Reading

“Digital Pathology Stands to Reduce Cancer Misdiagnoses”

| May 21, 2017 | 0 Comments

With the ink dry about a month on the recent FDA approval of Philips Intellisite Pathology Solution (PIPS) for primary diagnosis, I came across this headline and others like it last week. Well known, respected pathologists and pathology informaticians at well-known cancer centers provided quotes for the articles. When you contribute to an article, you […]

Continue Reading

Leslie’s Story & Efforts for Metastatic Breast Cancer Patients

Last October I wrote about “Riding a Bike Versus the Hard Part” after riding in a 3-day event where I met many patients, their friends and family and the challenges they face every day. Leading up to both of these rides on the East and West coast last Fall I met Leslie through social media […]

Continue Reading

Leveraging Technology For Integrated Diagnostic Reporting

| March 9, 2017 | 0 Comments

By Chrystal Adams, Associate Vice President, XIFIN and Don Rule, CEO, Translational Software There is ongoing effort in healthcare to integrate and expand the use of patient data to improve clinical decision making and support cost-effective, patient-centered care. Much of the needed data resides within the diagnostic specialties of pathology, radiology, laboratory, and molecular diagnostics. […]

Continue Reading

Different Sides of the Pond

| February 9, 2017 | 0 Comments

Great story in The Pathologist entitled “An Ocean Apart” — How pathology differs on either side of the Atlantic – and how it doesn’t by Michael Schubert What exactly is a boot? Or a biscuit? Or a chip? If you pictured part of a car, a sweet treat, and a French fry, you may be […]

Continue Reading

Trump Says ACA May Not Be Replaced Until Next Year

| February 6, 2017 | 0 Comments

Politico (2/5, Palmieri) reports that in an interview with Fox News’ Bill O’Reilly which aired before the Super Bowl, President Trump “walked back his recent vow that Obamacare would be replaced in short order,” saying that “the process is ‘complicated’ and ‘maybe it’ll take till sometime into next year.’” Trump said, “It statutorily takes a […]

Continue Reading

To Sign Out or Not to Sign Out? Part 2: The Fax Machine

| January 13, 2017 | 0 Comments

I received a lot of feedback offline about Part 1 of this post (see: “To Sign Out or Not to Sign Out? Part 1” ) from a number of pathologists echoing my sentiments on the issue of turnaround time in general and needs/expectations from clinicians and patients about getting their results in a timely manner. […]

Continue Reading

Mammograms Tied to Over Diagnosis of Breast Cancer

| January 10, 2017 | 0 Comments

This kind of news seems to come up with some regular frequency – “To screen or not to screen, that is the question”. This Danish study recently reported in the Annals of Internal Medicine found that screening was not associated with a lower incidence of advanced tumors and argues that slow-growing, clinically less aggressive tumors may […]

Continue Reading

To Sign Out or Not to Sign Out? Part 1

| December 27, 2016 | 0 Comments

That is the question. Every year. Around the holidays or three-day weekends. Normally biopsies or surgical specimens collected the day before are reviewed the next day. In a majority of cases, the case can be “signed out” meaning your opinion goes into a surgical pathology report and becomes part of the medical record. New malignancies, […]

Continue Reading

Will Cancer Still Be a Surgical Disease in 2027?

| December 25, 2016 | 0 Comments

As we get ready to flip the calendars over to 2017, a year that seems almost made up from the time I was about 10 in 1980 thinking wasn’t even a real number. By now we were supposed to be flying around in our transport pods with flux capacitors, without roads, carrying light sabers perhaps […]

Continue Reading

Patients Protest at Medical Conference

| December 11, 2016 | 0 Comments

It has been said there are only two certainties in life – death and taxes. Actually, there are a few more. The annual ASCO meeting always takes place during the first week of June, the annual RSNA meeting happens the week after Thanksgiving. The annual ASH meeting and the San Antonio Breast Cancer Symposium (SABCS) […]

Continue Reading

FDA Delays Final Guidance on Regulating LDTs

| November 25, 2016 | 0 Comments

medpagetoday.com posted a brief but concise article earlier this week on the issue of FDA regulating laboratory developed tests (LDTs). While the FDA has had the ability to regulate these tests since 1976, largely once regarded as “simple and scarce” as the article mentions, not before a draft guidance issued in 2014 has the FDA […]

Continue Reading

Cancer Moonshot Initiative Grounded

| November 23, 2016 | 0 Comments

Previous posts on this matter referenced that even with the funding proposed in the hundreds of millions dollars (estimated $750 million proposal) a lot more would be required. I believe one critic I referenced said that even with that amount of funding, if approved, wouldn’t “get us off the ground” when it came to this […]

Continue Reading